Junyi Hu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Research top 10%
Papers in
-
- Renal cell carcinoma treatment 3
- Prostate Cancer Treatment and Research 2
-
- Crystal structures of chemical compounds 3
- Co-authors
- Ke Chen (12 shared papers)Lilong Liu (13 shared papers)Yaxin Hou (10 shared papers)Lijie Zhou (7 shared papers)Ming Xiong (5 shared papers)Zhaohui Chen (6 shared papers)Yu Yang (2 shared papers)Zhen Tao (4 shared papers)
- Journals
- Journal of Energy Storage (3 papers)Frontiers in Oncology (2 papers)Molecular Therapy (2 papers)Nature Genetics (2 papers)Nature Communications (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Junyi Hu
42 papers receiving 1.3k citations
Junyi Hu's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 340
- Cancer Research 139
- Pulmonary and Respiratory Medicine 234
- Immunology 106
- Molecular Biology 336
Countries citing papers authored by Junyi Hu
This map shows the geographic impact of Junyi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Hu more than expected).
Fields of papers citing papers by Junyi Hu
This network shows the impact of papers produced by Junyi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Hu. The network helps show where Junyi Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junyi Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma Hit paper breakdown → | 2020 | 491 |
| 2 | 2020 | 140 | |
| 3 | Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression Hit paper breakdown → | 2024 | 109 |
| 4 | 2020 | 92 | |
| 5 | 2020 | 58 | |
| 6 | 2022 | 53 | |
| 7 | 2023 | 42 | |
| 8 | 2021 | 41 | |
| 9 | 2019 | 29 | |
| 10 | 2021 | 28 | |
| 11 | 2021 | 23 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 22 | |
| 14 | 2014 | 21 | |
| 15 | 2007 | 20 | |
| 16 | 2020 | 15 | |
| 17 | 2022 | 15 | |
| 18 | 2013 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2025 | 9 |
About Junyi Hu
Junyi Hu is a scholar working on Pulmonary and Respiratory Medicine, Inorganic Chemistry, Oncology, Infectious Diseases and Surgery, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Crystal structures of chemical compounds (3 papers), COVID-19 Clinical Research Studies (3 papers), Supercapacitor Materials and Fabrication (3 papers), Renal cell carcinoma treatment (3 papers), Prostate Cancer Treatment and Research (2 papers) and Sesquiterpenes and Asteraceae Studies (2 papers). The work is most often cited by research in Oncology (340 citations), Cancer Research (139 citations), Pulmonary and Respiratory Medicine (234 citations), Immunology (106 citations) and Molecular Biology (336 citations). Junyi Hu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ke Chen, Lilong Liu, Yaxin Hou, Lijie Zhou, Ming Xiong, Zhaohui Chen, Yu Yang, Zhen Tao, Xiong Wen Yang and Zhengshuai Song. Their work appears in journals such as Journal of Energy Storage, Frontiers in Oncology, Molecular Therapy, Nature Genetics and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.